Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (346)	8/16/2007 9:30:58 PM
From: buffalodon2003	of 370

I was also encouraged by detail in news release. The midpoint was promising before and does sound cautiously good now. In terms of timing, I wonder what final affects the Phase III conclusion on the trial halt will have versus this phase II. I know that this is stand alone in the phase II, but I take todays news with a grain of salt. I think that fact that subprime mtg market overshadows this and may have hampered the price, it nonetheless, is a great buy opportunity. I think however, the buy here may be better at somewhat a large quantity, but a later short term dump at $1.10 a share. The key would be to recover some of drop off from earlier longer priced shares. In past, this news may have driven the stock up .15 - .35 a share. Patience is the order of the day. As always, it is good to see your posts. There are few these days.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next